Related Experiment Video
Updated: Feb 1, 2026

06:44
Isolation of Small Noncoding RNAs from Human Serum
Published on: June 19, 2014
18.6K
LONG-NONCODING RNAs in gastroesophageal cancers
Giuseppe Nicolò Fanelli1,2, Pierluigi Gasparini3, Irene Coati1
1Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padua, Padua, PD, Italy.
Non-Coding RNA Research
|December 12, 2018
Summary
Long non-coding RNAs (lncRNAs) show promise as biomarkers for early diagnosis and new targeted therapies in gastro-esophageal cancers. Understanding lncRNAs
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Gastro-esophageal cancers have poor survival rates and are diagnosed late due to limited understanding of pathogenesis and lack of reliable markers.
- Advances in understanding the cancer molecular landscape offer opportunities for targeted therapies and early diagnostic biomarkers.
- Long non-coding RNAs (lncRNAs), transcripts over 200 nucleotides without protein-coding capacity, are increasingly recognized for their roles in oncogenesis.
Purpose of the Study:
- To review the role of lncRNAs in gastro-esophageal carcinogenesis.
- To assess the potential of lncRNAs as noninvasive biomarkers for early diagnosis.
- To evaluate lncRNAs in the development of next-generation targeted therapies for these cancers.
Main Methods:
- Literature review focusing on lncRNAs in gastro-esophageal cancers.
- Analysis of studies demonstrating lncRNA functions in oncogenic processes.
- Critical assessment of lncRNA potential as biomarkers and therapeutic targets.
Main Results:
- lncRNAs are functional genomic elements involved in key oncogenic processes.
- lncRNAs can modulate gene expression at multiple levels, influencing tumorigenesis.
- Emerging evidence highlights lncRNAs' significant role in gastro-esophageal carcinogenesis.
Conclusions:
- lncRNAs represent promising targets for novel therapeutic strategies in gastro-esophageal cancers.
- lncRNAs hold potential as reliable noninvasive biomarkers for early detection.
- Further research into lncRNAs could revolutionize the management of these malignancies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs
3.7K
3.7K
siRNA - Small Interfering RNAs
18.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
piRNA - Piwi-interacting RNAs
7.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Small interfering RNAs (siRNA)
4.5K
4.5K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.6K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.6K

